Skip to content

HCW Biologics Inc.

HCWB· NasdaqCore metricsCIK 1828673

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -7.53%
Market cap
$2.70M
3.14M shares
Filings
344
$51.17K
Q3 2026−97.9% FY25 yoy
-$3.22M
Q3 2026N/M FY25 yoy
-$2.59M
Q3 2026N/M FY25 yoy
-$13.39M
FY 2025derivedN/M FY25 yoy
-$2.83
Q3 2026N/M FY25 yoy
$955.46K
Q3 2026−58.2% FY25 yoy
$2.70M
—
0.4×
0.4×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$0.8668.84%$1.90past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$54.23KFY 2025
$6.72M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$54,232reported
FY 20242024-12-31$2,566,792reported
FY 20232023-12-31$2,841,794reported
FY 20222022-12-31$6,722,090reported
FY 20212021-12-31$0reported
FY 20202020-12-31$4,099,750reported

Pharmaceutical preparations

HCW Biologics Inc. is the 248th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

HCW Biologics Inc. · CIK 1828673 · Engraved from SEC EDGAR